Works matching IS 20050380 AND DT 2023 AND VI 34 AND IP 3


Results: 15
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Interleukin-34 cancels anti-tumor immunity by PARP inhibitor.

    Published in:
    Journal of Gynecologic Oncology, 2023, v. 34, n. 3, p. 1, doi. 10.3802/jgo.2023.34.e25
    By:
    • Takayoshi Nakamura;
    • Nabeel Kajihara;
    • Naoki Hama;
    • Takuto Kobayashi;
    • Ryo Otsuka;
    • Nanumi Han;
    • Haruka Wada;
    • Yoshinori Hasegawa;
    • Nao Suzuki;
    • Ken-ichiro Seino
    Publication type:
    Article
    12
    13
    14

    Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer.

    Published in:
    Journal of Gynecologic Oncology, 2023, v. 34, n. 3, p. 1, doi. 10.3802/jgo.2023.34.e24
    By:
    • Naoya Murakami;
    • Miho Watanabe;
    • Takashi Uno;
    • Shuhei Sekii;
    • Kayoko Tsujino;
    • Takahiro Kasamatsu;
    • Yumiko Machitori;
    • Tomomi Aoshika;
    • Shingo Kato;
    • Hisako Hirowatari;
    • Yuko Kaneyasu;
    • Tomio Nakagawa;
    • Hitoshi Ikushima;
    • Ken Ando;
    • Masumi Murata;
    • Ken Yoshida;
    • Hiroto Yoshioka;
    • Kazutoshi Murata;
    • Tatsuya Ohno;
    • Noriyuki Okonogi
    Publication type:
    Article
    15